secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001437749-24-018348
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key receives Nasdaq delisting notice for late 10-Q; restating prior periods
-------------------------------------------------------------------------------

- Received Nasdaq notice on May 22, 2024 for non-compliance with Listing Rule 5250(c)(1) due to late 10-Q filing for quarter ended March 31, 2024.
- Company remains delinquent on 2023 10-K; restating 2023 quarterly financial statements (Q1, Q2, Q3 2023).
- Must submit compliance plan by June 17, 2024; potential extension to October 14, 2024 if plan accepted.
- No immediate effect on listing or trading of common stock on Nasdaq Capital Market.
- Company intends to file Form 10-Q and Form 10-K as soon as practicable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924018348/0001437749-24-018348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924018348/bkyi20240523_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-018348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer